Diastolic dysfunction and COPD exacerbation

Postgraduate Medicine

Volumn 121, Issue 4, 2009, Pages 76-81

  Abusaid, Ghassan H ^a   Barbagelata, Alejandro ^a   Tuero, Enrique ^a   Mahmood, Asif ^a   Sharma, Gulshan ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Congestive heart failure; COPD; Diastolic dysfunction; Diastolic heart failure; Length of stay; Pulmonary hypertension; Risk factors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE RELAXATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; AGED; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; FEMALE; GLUCOCORTICOIDS; HEART FAILURE, DIASTOLIC; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 68249083256     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.07.2033     Document Type: Article

References (33)

1. Mathers CD, Loncar D. Prejections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 suppl): 121S-126S.
3. Voelkel NF, Tuder R. COPD: exacerbation. Chest. 2000; 117(5 suppl 2):376S-379S.
4. Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555.
5. Vestbo J. Clinical assessment staging, and epidemiology of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2006;3(3):252-256.
6. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 pt 1):1418-1422.
7. Dusser D. Chronic obstructive pulmonary disease exacerbations and their impact on the long-term natural history of the disease [in French]. Presse Med. 2008;37(11):1599-1603.
8. Calverley PM, Anderson JA, Celli B, et al: TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;22;35(8):775-789.
9. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;9;359(15):1543-1554.
10. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med. 2004;351(11):1097-1105.
11. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101(17):2118-2121.
12. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171-180.
13. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005;3:9.
14. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30(6):1527-1533.
15. Nishimura RA, Tajik J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30(1):8-18.
16. Ommen SR, Kishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler catheterization study. Circulation. 2000;102(15):1788-1794.
17. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204.
18. Chabot F, Gomez E, Guillaumot A, Kheir A, Chaouat A. Acute exacerbations of Chronic obstructive pulmonary disease [in French]. Presse Med. 2009;38(3):495-1495
19. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204-1213.
20. Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Slutly Group. Respiration. 2000;67(5):495-501.
21. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371-384.
22. Feifer RA, Aubert R, Verbrugge RR, Khalid M. Disease management. 2002;5(3):143-156.
23. Barnes PJ. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc. 2008;5(8):857-864.
24. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321(7255):215-218.
25. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease. Saskatchewan Canada cardiosvascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63-70.
26. Rutten FH, Cramer MJ, Grobbee DH, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887-1894.
27. Tutar E, Kaya A, Gülec S, et al. Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Am J Cardiol. 1999;83(9):1414-1417.
28. Boussuges A, Pinet C, Molenat F, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000;162(2 pt 1):670-675.
29. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest. 1996; 109(6):1446-1451.
30. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29(1):153-159.
31. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiosvascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation. 2003;107(11):1514-1519.
32. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245-1257.
33. Steele P, Ellis JH, Van Dyke D, Sutton F, Creagh E, Davies H. Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med. 1975;59(1):21-28.